期刊文献+

类风湿关节炎患者关节液中HSP72水平变化与疾病活动性及炎症因子水平相关性分析 被引量:2

The change of HSP72 level in synovial fluid of active rheumatoid arthritis patients and its correlation with the expression of inflammatory cytokines
下载PDF
导出
摘要 目的观察类风湿关节炎(RA)患者关节液中热休克蛋白72(HSP72)的水平变化,并对其与疾病活动性相关指标和细胞因子之间的相关性进行分析。方法采用酶联免疫吸附法(ELISA)检测RA患者和骨关节炎(OA)患者关节液中HSP72、TNF-α、IL-6、IL-10的表达水平。结果活动期RA患者关节液中HSP72水平明显高于非活动期RA患者和OA对照组(P<0.01)。活动期RA患者关节液中TNF-α、IL-6的水平均高于非活动期RA患者和OA对照者(P<0.01),关节液中IL-10在各组之间无显著差异。RA患者关节液中HSP72的水平与血沉(ESR)、C反应蛋白(CRP)、风湿因子(RF)呈正相关;RA患者关节液中HSP72的水平与关节液中TNF-α、IL-6水平呈正相关。结论关节液中HSP72可能与RA的炎症相关,与RA病情活动有关。 We aimed to determine HSP72 level in synovial fluid of RA patients,and explore its association with disease activities and inflammatory cytokines.We used enzyme linked immunosorbent assay(ELISA) to measure the levels of HSP72,TNF-α,IL-6,and IL-10 in synovial fluid of RA patients.The results showed that the levels of HSP72 were significantly higher in active RA patients than those in osteoarthritis(OA) or inactive groups,and the level of HSP72 were correlated with the levels of RA activity associated-markers such as erythrocyte sedimentation rate(ESR),C-reactive protein(CRP) and rheumatoid factor(RF).Moreover,the level of HSP72 was correlated with TNF-α and IL-6 in synovial fluid of RA.All the result suggested that the increased HSP72 in synovial fluid may involve in the course of RA inflammation,and may serve as a marker of disease activity in RA.
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第5期455-456,共2页 Immunological Journal
基金 浙江省自然科学基金(Y2090233)
关键词 类风湿关节炎 热休克蛋白72 细胞因子 Rheumatoid arthritis Heat shock protein 72 Cytokine
  • 相关文献

参考文献4

  • 1尧荣凤,陈小文,傅颖媛.类风湿性关节炎患者血清IL-25及IL-27的水平分析[J].免疫学杂志,2010,26(12):1078-1080. 被引量:7
  • 2Martin CA,Carsons SE,Kowalewski R,et al.Aberrantextracellular and dendritic cell (DC)surface expression ofheatshock protein (hsp)70 in the rheumatoid joint:possiblemechanisms of hsp/DC-mediated cross-priming[].JImmunol.2003
  • 3Miossec P.An update on the cytokine network in rheumatoid arthritis[].Current Opinion in Rheumatology.2004
  • 4Fleshner M,Johnson JD.Endogenous extra-cellular Heat Shock Protein72:Releasing signal(s)and function[].International Journal of Hyperthermia.2005

二级参考文献13

  • 1Amett FC, Edworthy SM, Bloch DA, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis [J]. Arthritis Rheum, 1988:31 (3):315-324.
  • 2Honorati MC, Neri S, Cattini L, et al.Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts [J]. Osteoarthritis Cartilage, 2006, 14(4):345-352.
  • 3Moseley TA, Haudenschild DR, Rose L, et al. Interleukin-17 family and IL-17 receptors[J]. Cytokine Growth Factor Rev, 2003, 14(2):155-174.
  • 4Pflanz S, Timans JC, Cheung J, Rosales R, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells[J]. Immunity, 2002, 16(6):779-790.
  • 5Yoshimura T, Takeda A, Hamano S, et al. Two-sided roles of IL-27: induction of Thl differentiation on naive CD4+ cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4CF cells partially through STAT3-dependent mechanism [J]. Immunol, 2006, 20(177): 5377-5385.
  • 6Amadi-Obi A, Yu CR, Liu X, et al.TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STATl[J]. Nat Med, 2007, 13(6):711-718.
  • 7Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system[J]. Nat Immunol, 2006, 7: 937-945.
  • 8Batten M, Li J, Yi S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T helper cells [J].Nat Immunol, 2006, 7: 929-936.
  • 9El-behi M, Ciric B, Yu S, et at. Differential effect of IL-27 on developing versus committed Thl7 Cells [J]. Immunol, 2009, 183(8): 4957-4967.
  • 10Yoshimoto T, Yoshimoto T, Yasuda K, et al. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells:a novel therapeutic way for Th2-mediated allergic inflammation [J]. Immunol, 2007, 179: 4415-4423.

共引文献6

同被引文献24

  • 1赛青.类风湿关节炎患儿外周血和关节滑液中肿瘤坏死因子-α水平分析[J].河南科技大学学报(医学版),2007,25(1):17-18. 被引量:3
  • 2Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis[J]. Annu Rev Immunol, 1996, 14: 397- 440.
  • 3Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells[J]. Immunity, 2002, 16(6): 779-790.
  • 4Yoshimura T,Takeda A,Hamano S,et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4^+T cells versus suppressionof proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4^+ T cells partially through STAT3- dependentmechanism[J]. Immunol, 2006, 177(8) : 5377- 5385.
  • 5Ferraccioli G, Gremese E. Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA)[J]. Intern Emerg Med, 2011, 6(Suppl 1): 11-15.
  • 6Llamas Covarrubias MA, Valle Y, Navarro Hern6ndez RE, et al. Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course [J]. Rheumatol Int, 2012, 32(8): 2307-2311.
  • 7Wakabayashi K, Otsuka K, Sato M, et al. Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity[J]. Mod Rheumatol, 2012, 22(1): 59-65.
  • 8Kudrin A, Scott M, Martin S, et al. Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine[J]. J Biol Chem, 2006, 281(40): 29641-29651.
  • 9Dasgupta B, Chew T, de Roche A, et al. Blocking platelet/ endothelial cell adhesion molecule 1 (PECAM) inhibits disease progression andprevents joint erosion in established collagen antibody-induced arthritis [J]. Exp Mol Pathol, 2010, 88(1): 210-215.
  • 10Hubert M, Be' atrice A, Jennifer D, et al. Association between the level of circulating bioactive tumor necrosis factor-or and the tumor necrosis factor-c gene polymorp- hism at-308 in patients with rheumatoidarthritis treated with a tumor necrosis factor-or inhibitor[J]. Arthritis Rheum, 2008, 58(5): 1258-1263.

引证文献2

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部